Pharminent

Eli Lilly licenses Adimab antibody discovery and optimization tech

Adimab, LLC is transferring its proprietary antibody discovery and optimization platform to Lilly research sites in San Diego and New York. http://www.outsourcing-pharma.com/Preclinical-Research/Eli-Lilly-licenses-Adimab-antibody-discovery-and-optimization-tech

Filed under: R&D